REDUCEDT+30
Denton John Russel
Caris Life Sciences Inc · NASDAQ
−7,500 sh · $238.6K
Filed 23 Sept 2026SEC Form 4view source
Coatue Management
13F filer
$175.0M
9,819,992 sh
Duquesne Family Office
13F filer
$33.8M
1,894,450 sh
ARK Investment Management
13F filer
$11.0M
408,725 sh
Renaissance Technologies
13F filer
$8.0M
449,900 sh
Spetzler David Baxley
US insider
$3.0M
652,788 sh
Soros Fund Management
13F filer
$1.7M
55,650 sh
Denton John Russel
Caris Life Sciences Inc · NASDAQ
−7,500 sh · $238.6K
Brille Brian J
Caris Life Sciences Inc · NASDAQ
+400,000 sh · $976.0K
Brille Brian J
Caris Life Sciences Inc · NASDAQ
−400,000 sh · $12.1M
Spetzler David Baxley
Caris Life Sciences Inc · NASDAQ
+250,000 sh · $610.0K
Spetzler David Baxley
Caris Life Sciences Inc · NASDAQ
−84,900 sh · $2.1M
Spetzler David Baxley
Caris Life Sciences Inc · NASDAQ
+1,000,000 sh · $2.4M
Spetzler David Baxley
Caris Life Sciences Inc · NASDAQ
−119,212 sh · $3.0M
Spetzler David Baxley
Caris Life Sciences Inc · NASDAQ
−393,100 sh · $9.7M
Coatue Management
Caris Life Sciences Inc · NASDAQ
9,819,992 sh · $175.0M
Duquesne Family Office
Caris Life Sciences Inc · NASDAQ
1,894,450 sh · $33.8M